Healthcare -
Biotechnology - NASDAQ - US
$ 4.975
-2.26 %
$ 216 M
Market Cap
-2.43
P/E
ABEO - REVENUE
Revenue ABEO - Abeona Therapeutics Inc.
3.5 M
LAST VALUE
8.01%
2 YEAR CAGR
3.14%
5 YEAR CAGR
5.54%
10 YEAR CAGR